CLINICAL_TRIALS
trial_result
· 2017-06-12
Clinical Trial Update: Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate) [Phase 4]
Summary
A Phase 4 study, sponsored by Dey, evaluating the long-term safety of Perforomist (formoterol fumarate) in chronic obstructive pulmonary disease has completed a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dey | Conditions: COPD | Phase 4 | Status: COMPLETED | Results posted: 2017-06-12